首页> 美国卫生研究院文献>Genomics Society and Policy >Neoliberalising Bioethics: Bias Enhancement and Economistic Ethics
【2h】

Neoliberalising Bioethics: Bias Enhancement and Economistic Ethics

机译:新自由主义的生物伦理学:偏见增强和经济伦理学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In bioethics there is an ongoing debate about the ethical case for human enhancement through new biomedical technologies. In this debate there are both supporters and opponents of human enhancement technologies such as genetic improvements of cognitive abilities (eg, intelligence). The supporters argue that human enhancement will lead to healthier and therefore better lives, meaning that any delays to the introduction of such technologies is problematic. In contrast, the opponents argue that new technologies will not solve problems such as inequality and social justice. In order to overcome opposition to human enhancement, Bostrom and Ord have outlined a test to evaluate ethical arguments for "status quo bias" or what they call "intuitive judgements" in the assessment of human enhancement. This article is a response to their paper in which I raise a number of problems with their position, particularly with their "status quo bias" test and the incorporation of economistic thinking into their ethical arguments.
机译:在生物伦理学中,关于通过新的生物医学技术促进人类生存的伦理学案例一直在争论。在这场辩论中,既有人类增强技术的支持者,也有反对者,例如认知能力(如智力)的遗传改良。支持者认为,人类的进步将带来更健康的生活,从而改善生活,这意味着任何延迟采用此类技术都是有问题的。相反,反对者则认为新技术不会解决不平等和社会正义之类的问题。为了克服对人类增强的反对,Bostrom和Ord概述了一种测试,用于评估人类增强评估中“现状偏见”或所谓的“直觉判断”的伦理论据。本文是对他们论文的回应,其中我对他们的立场提出了许多问题,尤其是关于他们的“现状偏差”检验以及将经济学思想纳入其道德论据中的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号